Immunogenetic Aspects of Sarcopenic Obesity

Area of Science:

• Immunogenetics
• Obesity research
• Sarcopenia

Background:

• Sarcopenic obesity (SO) combines obesity with sarcopenia, characterized by impaired muscle function and altered body composition.
• Pathogenesis involves aging, chronic inflammation, insulin resistance, and hormonal changes.
• While genetic factors are known in obesity, their specific role in SO requires further elucidation.

Purpose of the Study:

• To analyze immunogenetic and non-genetic factors influencing sarcopenic obesity (SO) development.
• To summarize recent findings on the impact of immunogenetics on SO.

Main Methods:

• Literature review of immunogenetic and non-genetic factors.
• Analysis of the role of specific genes (e.g., FTO, ADRB2, MC4R) in SO.
• Examination of the contribution of systemic inflammation and cytokines (e.g., MCP-1, IL-15) in SO pathophysiology.

Main Results:

• Genetic variants associated with obesity (e.g., FTO, ADRB2, MC4R) may play a role in SO, but require more research.
• Systemic inflammation from adipose tissue, involving cytokines like MCP-1 and IL-15, significantly impacts SO pathophysiology.
• Imbalances in cytokine levels, such as a lack of anti-inflammatory IL-15, may increase SO risk.

Conclusions:

• The interplay of immunogenetic and non-genetic factors is crucial in sarcopenic obesity.
• Further research is needed to fully understand the mechanisms of specific cytokines and gene variants in SO development.